Quick Access Forecast in this page:

Regeneron Pharmaceuticals Inc. (REGN) stock prediction

Will Regeneron Pharmaceuticals Inc. stock go up? Is Regeneron Pharmaceuticals Inc. stock a good buy now?

From AI system, total return is 1471.44% from 1375 forecasts. Forecast for Apr. 2021 is $460.56 , for Mar. 2022 is $677.77 , for Mar. 2024 is $676.33 , for Mar. 2026 is $464.16 , and for Mar. 2031 is $613.67.

Since closing price on 2021-03-08 is $463.19 and forecast for Mar. 2022 is $677.77, Regeneron Pharmaceuticals Inc. stock is a good 1 year investment. Please, see more forecasts below.

Table of contents

Statistics

Statistics from all past short term forecast signals in AI Pickup
Total return : 1471.44 %
Number of direction forecasts : 1375

Click to see the forecast history of all tickers

Chart for Regeneron Pharmaceuticals Inc. (REGN) stock

<REGN Chart by Tradingview>

Long term forecast for Regeneron Pharmaceuticals Inc. stock

REGN long term forecast chart
Date
Price
Apr. 2021
$460.557052595526
May. 2021
$443.202053625225
Jun. 2021
$446.926176673508
Jul. 2021
$473.576988715913
Aug. 2021
$520.005594251381
Sep. 2021
$578.152590505678
Oct. 2021
$624.647740839088
Nov. 2021
$652.409825704907
Dec. 2021
$653.947693696873
Jan. 2022
$657.602560996727
Feb. 2022
$665.948023266295
Mar. 2022
$677.766393839064
Apr. 2022
$655.611783543489
May. 2022
$623.095125276476
Jun. 2022
$583.668471095486
Jul. 2022
$557.984709310615
Aug. 2022
$547.686495186632
Sep. 2022
$548.893735657268
Oct. 2022
$558.940590452145
Nov. 2022
$576.407895064598
Dec. 2022
$607.07051622091
Jan. 2023
$669.746607087938
Feb. 2023
$735.556050673238
Mar. 2023
$734.450127458783
Apr. 2023
$703.66500748649
May. 2023
$678.766336962501
Jun. 2023
$652.005062724274
Jul. 2023
$599.5791117926
Aug. 2023
$542.686996445488
Sep. 2023
$490.322493724841
Oct. 2023
$439.925996473347
Nov. 2023
$430.178213736138
Dec. 2023
$486.13194260886
Jan. 2024
$554.326950330241
Feb. 2024
$610.631114735848
Mar. 2024
$676.327927364936
Apr. 2024
$711.869717206799
May. 2024
$691.891964005854
Jun. 2024
$656.83120521831
Jul. 2024
$630.845045943175
Date
Price
Aug. 2024
$601.992905959748
Sep. 2024
$554.835127035432
Oct. 2024
$502.245832300447
Nov. 2024
$449.734215333401
Dec. 2024
$438.347934122169
Jan. 2025
$464.198835041032
Feb. 2025
$510.001030284093
Mar. 2025
$561.109748447393
Apr. 2025
$618.110735566043
May. 2025
$667.69698393614
Jun. 2025
$669.765113843259
Jul. 2025
$638.264736694615
Aug. 2025
$614.85282370942
Sep. 2025
$602.891604119017
Oct. 2025
$577.396343757972
Nov. 2025
$528.940814762778
Dec. 2025
$477.948992784455
Jan. 2026
$446.152001506584
Feb. 2026
$439.532655630763
Mar. 2026
$464.162978202598
Apr. 2026
$515.725834791392
May. 2026
$568.678794497635
Jun. 2026
$623.029050376619
Jul. 2026
$652.91890606026
Aug. 2026
$665.944336373633
Sep. 2026
$632.213461456733
Oct. 2026
$605.418246118415
Nov. 2026
$583.965193662732
Dec. 2026
$542.974863241145
Jan. 2027
$490.597203374137
Feb. 2027
$448.288013613885
Mar. 2027
$421.304947479858
Apr. 2027
$422.444920232423
May. 2027
$469.862408213343
Jun. 2027
$535.314765400564
Jul. 2027
$596.051189267526
Aug. 2027
$642.863014763762
Sep. 2027
$661.791593980436
Oct. 2027
$645.233831329197
Nov. 2027
$606.1559861108
Date
Price
Dec. 2027
$583.521176119054
Jan. 2028
$554.854754316954
Feb. 2028
$507.838776176083
Mar. 2028
$460.537172291958
Apr. 2028
$429.374760303961
May. 2028
$413.684284932354
Jun. 2028
$436.812451766631
Jul. 2028
$496.072817312719
Aug. 2028
$558.751329962182
Sep. 2028
$618.268765906401
Oct. 2028
$650.889090920016
Nov. 2028
$660.632174676382
Dec. 2028
$617.744793396375
Jan. 2029
$582.678142809774
Feb. 2029
$563.940125339295
Mar. 2029
$528.856413837633
Apr. 2029
$481.437877622525
May. 2029
$447.012999381088
Jun. 2029
$421.849161753516
Jul. 2029
$418.807403015681
Aug. 2029
$457.866199288661
Sep. 2029
$519.860504181345
Oct. 2029
$580.752428168211
Nov. 2029
$633.748654644218
Dec. 2029
$657.699143126059
Jan. 2030
$641.111306997423
Feb. 2030
$591.736693495303
Mar. 2030
$564.111529702054
Apr. 2030
$544.29762634851
May. 2030
$502.219734883764
Jun. 2030
$462.639207153162
Jul. 2030
$434.629666726937
Aug. 2030
$416.716645708502
Sep. 2030
$430.383378468954
Oct. 2030
$483.775078401928
Nov. 2030
$546.59886185146
Dec. 2030
$608.542309313018
Jan. 2031
$650.699541262002
Feb. 2031
$665.608323097336
Mar. 2031
$613.671716801474

Analyst rating for Regeneron Pharmaceuticals Inc. stock

Date
Firm
Analysis
2021-02-23
Credit Suisse
Price target is $760.0000. Prior price target was $753.0000.
 Analyst rating is Outperform.
2021-02-08
SVB Leerink
Price target is $640.0000. Prior price target was $623.0000.
 Analyst rating is Outperform.
2021-01-25
BMO Capital
Price target is $630.0000. Analyst rating is Outperform. Prior analyst rating was Market Perform
2021-01-13
Benchmark
Price target is $590.0000. Analyst rating is Buy. Prior analyst rating was Hold
2020-11-06
Credit Suisse
Price target is $737.0000. Prior price target was $745.0000.
 Analyst rating is Outperform.
2020-11-06
SVB Leerink
Price target is $653.0000. Prior price target was $650.0000.
 Analyst rating is Outperform.
2020-11-06
BMO Capital
Price target is $630.0000. Prior price target was $626.0000.
 Analyst rating is Market Perform.
2020-10-13
Morgan Stanley
Price target is $609.0000. Prior price target was $611.0000.
 Analyst rating is Equal-Weight.
2020-10-06
SVB Leerink
Price target is $650.0000. Prior price target was $629.0000.
 Analyst rating is Outperform.
2020-10-05
Cantor Fitzgerald
Price target is $690.0000. Analyst rating is Overweight. Prior analyst rating was Neutral
2020-08-20
Benchmark
Analyst rating is Hold. Prior analyst rating was Buy
2020-08-07
Credit Suisse
Price target is $725.0000. Prior price target was $716.0000.
 Analyst rating is Outperform.
2020-08-06
BMO Capital
Price target is $626.0000. Prior price target was $525.0000.
 Analyst rating is Market Perform.
2020-08-06
Morgan Stanley
Price target is $611.0000. Prior price target was $619.0000.
 Analyst rating is Equal-Weight.
2020-08-06
Citigroup
Price target is $635.0000. Prior price target was $585.0000.
 Analyst rating is Neutral.
2020-07-20
Credit Suisse
Price target is $716.0000. Prior price target was $700.0000.
 Analyst rating is Outperform.
2020-07-15
Morgan Stanley
Price target is $619.0000. Prior price target was $555.0000.
 Analyst rating is Equal-Weight.
2020-07-09
SunTrust Robinson Humphrey
Price target is $750.0000. Prior price target was $400.0000.
 Analyst rating is Buy. Prior analyst rating was Hold
2020-07-08
Canaccord Genuity
Price target is $700.0000. Prior price target was $660.0000.
 Analyst rating is Buy.
2020-07-01
Oppenheimer
Price target is $675.0000. Prior price target was $625.0000.
 Analyst rating is Outperform.
2020-06-24
Credit Suisse
Price target is $700.0000. Prior price target was $605.0000.
 Analyst rating is Outperform.
2020-06-12
Jefferies
Price target is $691.0000. Prior price target was $657.0000.
 Analyst rating is Buy.
2020-05-27
CFRA
Price target is $549.0000. Prior price target was $557.0000.
 Analyst rating is Hold.
2020-05-27
SVB Leerink
Price target is $625.0000. Prior price target was $622.0000.
 Analyst rating is Outperform.
2020-05-26
Wells Fargo
Price target is $734.0000. Analyst rating is Overweight. Prior analyst rating was Equal-Weight
2020-05-06
Baird
Price target is $510.0000. Prior price target was $487.0000.
 Analyst rating is Neutral.
2020-05-06
BMO Capital
Price target is $525.0000. Prior price target was $466.0000.
 Analyst rating is Market Perform.
2020-05-06
Morgan Stanley
Price target is $555. Prior price target was $409.
 Analyst rating is Equal-Weight.
2020-05-06
Credit Suisse
Price target is $605.0000. Prior price target was $596.0000.
 Analyst rating is Outperform.
2020-05-06
SVB Leerink
Price target is $622.0000. Prior price target was $604.0000.
 Analyst rating is Outperform.
2020-04-28
Canaccord Genuity
Price target is $575.0000. Prior price target was $550.0000.
 Analyst rating is Buy.
2020-04-28
Citigroup
Price target is $575.0000. Prior price target was $540.0000.
 Analyst rating is Neutral. Prior analyst rating was Buy
2020-04-17
Benchmark
Analyst rating is Buy. Prior analyst rating was Hold
2020-04-15
Morgan Stanley
Price target is $409. Prior price target was $410.0000.
 Analyst rating is Equal-Weight.
2020-04-15
JP Morgan
Price target is $429.0000. Prior price target was $375.0000.
 Analyst rating is Neutral.
2020-04-08
Benchmark
Analyst rating is Hold.
2020-04-07
SVB Leerink
Price target is $604.0000. Prior price target was $600.0000.
 Analyst rating is Outperform.
2020-04-06
Wells Fargo
Price target is $435.0000. Prior price target was $370.0000.
 Analyst rating is Equal-Weight.
2020-03-12
Argus Research
Price target is $540.0000. Prior price target was $430.0000.
 Analyst rating is Buy.
2020-03-11
Oppenheimer
Price target is $525.0000. Prior price target was $450.0000.
 Analyst rating is Outperform.
2020-03-04
CFRA
Price target is $487.0000. Prior price target was $460.0000.
 Analyst rating is Hold. Prior analyst rating was Buy
2020-02-26
Credit Suisse
Price target is $510.0000. Prior price target was $420.0000.
 Analyst rating is Outperform.
2020-02-26
Baird
Analyst rating is Neutral. Prior analyst rating was Outperform
2020-02-26
Canaccord Genuity
Price target is $550.0000. Prior price target was $409.0000.
 Analyst rating is Buy. Prior analyst rating was Hold
2020-02-25
Jefferies
Price target is $492.0000. Prior price target was $355.0000.
 Analyst rating is Buy. Prior analyst rating was Hold
2020-02-25
Evercore ISI Group
Analyst rating is Outperform. Prior analyst rating was In-Line
2020-02-11
Argus Research
Price target is $430.0000. Analyst rating is Buy. Prior analyst rating was Hold
2020-02-07
Morgan Stanley
Price target is $410.0000. Prior price target was $411.0000.
 Analyst rating is Equal-Weight.
2020-01-17
Morgan Stanley
Price target is $411.0000. Prior price target was $387.0000.
 Analyst rating is Equal-Weight.
2019-12-24
Raymond James
Analyst rating is Market Perform.
2019-12-16
Evercore ISI Group
Analyst rating is In-Line. Prior analyst rating was Outperform
2019-12-13
Credit Suisse
Analyst rating is Outperform. Prior analyst rating was Neutral
2019-11-12
SunTrust Robinson Humphrey
Price target is $360.0000. Analyst rating is Hold.
2019-11-07
Citigroup
Price target is $420.0000. Prior price target was $340.0000.
 Analyst rating is Buy. Prior analyst rating was Neutral
2019-11-06
BMO Capital
Price target is $358.0000. Prior price target was $344.0000.
 Analyst rating is Market Perform.
2019-11-06
Morgan Stanley
Price target is $387.0000. Prior price target was $375.0000.
 Analyst rating is Equal-Weight.
2019-11-06
Credit Suisse
Price target is $340.0000. Prior price target was $310.0000.
 Analyst rating is Neutral.

Financial Data for Regeneron Pharmaceuticals Inc. stock

Market Cap
49622470656
Held Percent By Insiders
2.9010000000000002%
Held Percent By Institutions
92.166%
Sector
Healthcare
Website
http://www.regeneron.com
currency
USD

Forward PE
11.65551
Trailing PE
15.176605
Enterprise Value
4.7190740992E10
Enterprise To Ebitda
13.365
Enterprise To Revenue
5.679

Average 10 day Volume
1003733
Average Volume
1043406
Fifty Two Week High
$664.64
Fifty Two Week Low
$418.01

Frequently Asked Questions for Regeneron Pharmaceuticals Inc. stock

Is Regeneron Pharmaceuticals Inc. a good long term stock?

For 1 year investment, Regeneron Pharmaceuticals Inc. (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals Inc. stock price forecast for Mar. 2022 is $677.766393839064
For 5 year investment, Regeneron Pharmaceuticals Inc. (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals Inc. stock price forecast for Mar. 2026 is $464.162978202598
For 10 year investment, Regeneron Pharmaceuticals Inc. (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals Inc. stock price forecast for Mar. 2031 is $613.671716801474

Is Regeneron Pharmaceuticals Inc. stock overvalued?

Regeneron Pharmaceuticals Inc. (REGN) stock is expected to go UP . Therefore, AI Pickup would say that Regeneron Pharmaceuticals Inc. (REGN) stock is NOT overvalued.

Will Regeneron Pharmaceuticals Inc. stock price go up?

Yes. The Regeneron Pharmaceuticals Inc. stock price forecast for Mar. 2022 is $677.766393839064

14 Days Historical Data for Regeneron Pharmaceuticals Inc. stock

Date
Close
Open
Low
High
2021-02-17
$481.68
$477.0
$476.56
$484.38
2021-02-18
$477.03
$479.9
$475.84
$481.76
2021-02-19
$470.37
$478.25
$470.27
$483.68
2021-02-22
$460.58
$468.27
$459.9
$468.27
2021-02-23
$468.03
$458.06
$448.0
$468.96
2021-02-24
$458.6
$466.11
$457.17
$469.47
2021-02-25
$453.19
$460.31
$448.33
$465.0
2021-02-26
$450.57
$455.84
$445.57
$457.17
2021-03-01
$463.05
$454.49
$453.83
$463.85
2021-03-02
$454.86
$463.13
$454.35
$466.0
2021-03-03
$446.73
$456.14
$446.38
$458.65
2021-03-04
$449.38
$445.37
$441.0
$451.85
2021-03-05
$461.57
$451.58
$449.3
$463.83
2021-03-08
$463.19
$456.49
$456.49
$473.5